XML 70 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Fair value of financial instruments and investments - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 29, 2020
Jan. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
May 31, 2019
Dec. 31, 2018
Aug. 23, 2018
Apr. 30, 2018
Aug. 31, 2015
ClearPoint Equity Investment                    
Share price (in USD per share)                 $ 27.04  
Unrealized (gains) losses     $ 14,310,000 $ 2,194,000            
ClearPoint Convertible note                    
Purchase of convertible note   $ 10,000,000.0 10,000,000              
Conversion price - convertible note   $ 6.00                
Term of convertible note   5 years                
Unrealized gain on convertible note     19,252,000              
Transfers from Level 1 to Level 2     0 0            
Transfers from Level 2 to Level 1     0 0            
Write downs of available for sale debt securities     0              
Increase in allowance for credit losses     0              
Realized gain (loss) from sale of marketable securities     700,000 0            
Deferred consideration payable     0              
Payments on deferred consideration obligation     38,100,000              
Issuance of common stock related to rights exchange     150,528,000              
Contingent consideration payable     240,400,000 356,300,000            
Deferred consideration payable       40,000,000            
3.00% Convertible senior notes due 2022 | Convertible debt                    
ClearPoint Convertible note                    
Principal     150,000,000 150,000,000           $ 150,000,000.0
Interest rate ( as a percent )                   3.00%
1.50% Convertible senior notes due 2026 | Convertible debt                    
ClearPoint Convertible note                    
Principal     287,500,000 287,500,000 $ 287,500,000          
Interest rate ( as a percent )         1.50%          
SARs                    
ClearPoint Convertible note                    
Contingent consideration payable- net sales milestones and royalties     0              
Level 2                    
ClearPoint Convertible note                    
ClearPoint convertible debt security     29,300,000              
Level 2 | 3.00% Convertible senior notes due 2022 | Convertible debt                    
ClearPoint Convertible note                    
Fair value of convertible notes     193,200,000 171,200,000            
Level 2 | 1.50% Convertible senior notes due 2026 | Convertible debt                    
ClearPoint Convertible note                    
Fair value of convertible notes     394,900,000 335,000,000.0            
Level 3                    
ClearPoint Convertible note                    
ClearPoint convertible debt security     0              
Contingent consideration payable- net sales milestones and royalties     101,200,000              
Level 3 | SARs                    
ClearPoint Convertible note                    
Contingent consideration payable- net sales milestones and royalties     0 3,186,000     $ 3,814,000      
Recurring basis | Level 1                    
ClearPoint Equity Investment                    
Fair value of equity investment     20,503,000 6,194,000            
ClearPoint Convertible note                    
ClearPoint convertible debt security     0              
Deferred consideration payable       0            
Stock appreciation rights liability       0            
Contingent consideration payable     0 0            
Contingent consideration payable- net sales milestones and royalties     0 0            
Recurring basis | Level 2                    
ClearPoint Equity Investment                    
Fair value of equity investment     0 0            
ClearPoint Convertible note                    
ClearPoint convertible debt security     29,252,000              
Deferred consideration payable       40,000,000            
Stock appreciation rights liability       0            
Contingent consideration payable     0 0            
Contingent consideration payable- net sales milestones and royalties     0 0            
Recurring basis | Level 3                    
ClearPoint Equity Investment                    
Fair value of equity investment     0 0            
ClearPoint Convertible note                    
Deferred consideration payable       0            
Stock appreciation rights liability       3,186,000            
Contingent consideration payable     139,200,000 290,500,000            
Contingent consideration payable- net sales milestones and royalties       65,800,000            
Regulatory Milestones | Nonrecurring basis | Level 3                    
ClearPoint Convertible note                    
Gain (loss) recognized on change in fair value on contingent consideration forfeited by Participating Rightholders     1,000,000.0              
Agilis                    
ClearPoint Convertible note                    
Development milestone payment obligations     40,000,000.0              
Deferred consideration payable               $ 38,100,000    
Agilis | Maximum                    
ClearPoint Convertible note                    
Development milestone payment obligations     60,000,000.0              
Priority review voucher amount     535,000,000.0              
Agilis | Development and Regulatory Milestone | Level 3 | Contingent Consideration Payable                    
ClearPoint Convertible note                    
Contingent consideration payable- net sales milestones and royalties     139,200,000 290,500,000     257,040,000      
Agilis | Net Sales Milestones and Royalties | Level 3 | Contingent Consideration Payable                    
ClearPoint Convertible note                    
Contingent consideration payable- net sales milestones and royalties     101,200,000 65,800,000     $ 53,200,000      
Agilis Merger Agreement | Agilis                    
ClearPoint Convertible note                    
Development milestone payment obligations     40,000,000.0         $ 40,000,000.0    
Payments on deferred consideration obligation     2,400,000              
Agilis Merger Agreement | Agilis | Maximum                    
ClearPoint Convertible note                    
Development milestone payment obligations     60,000,000.0              
Priority review voucher amount     $ 535,000,000.0              
Rights Exchange Agreement                    
ClearPoint Convertible note                    
Shares issued under Rights Exchange Agreement 2,821,176   2,821,176              
Cash consideration payment under Rights Exchange Agreement $ 36,900,000   $ 36,900,000              
Issuance of common stock related to rights exchange     150,500,000              
Transaction fees     2,000,000.0              
Rights Exchange Agreement | Regulatory Milestones                    
ClearPoint Convertible note                    
Amount of potential future milestone payments forfeited by Participating Rightholders     174,000,000.0              
Settled value of milestone payments     139,200,000              
Gain (loss) recognized on settlement of milestones     (11,300,000)              
Rights Exchange Agreement | Development Milestones                    
ClearPoint Convertible note                    
Amount of potential future milestone payments forfeited by Participating Rightholders     37,600,000              
Settled value of milestone payments     37,600,000              
Gain (loss) recognized on settlement of milestones     700,000              
Total | Recurring basis                    
ClearPoint Equity Investment                    
Fair value of equity investment     20,503,000 6,194,000            
ClearPoint Convertible note                    
ClearPoint convertible debt security     29,252,000              
Deferred consideration payable       40,000,000            
Stock appreciation rights liability       3,186,000            
Contingent consideration payable     139,200,000 290,500,000            
Contingent consideration payable- net sales milestones and royalties     $ 101,200,000 $ 65,800,000            
Common stock                    
ClearPoint Equity Investment                    
Shares purchased           $ 4,000,000.0        
Share price (in USD per share)           $ 3.10